Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$191.51 - $216.16 $6.43 Million - $7.26 Million
-33,600 Reduced 91.06%
3,300 $700,000
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $6.92 Million - $7.61 Million
36,900 New
36,900 $7.1 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Hunting Hill Global Capital, LLC Portfolio

Follow Hunting Hill Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunting Hill Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunting Hill Global Capital, LLC with notifications on news.